Clinical Trials

Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies

Immune Disorder HSCT Protocol

Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts

Baby Detect : Genomic Newborn Screening

Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation

Developing Newborn Screening for Infants With Primary Immunodeficiency

Diversion-p64 Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Gene Therapy for X-linked Severe Combined Immunodeficiency

Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector

Human Placental-Derived Stem Cell Transplantation

Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders

Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)

Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant

Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy

Early Check: Expanded Screening in Newborns

Natural History Study of SCID Disorders

Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases